Life Sciences Glycosylation Analysis
Glycosylation analysis plays an important role in the safety and efficacy of final drug products and, as such, is an important part of SGS Life Science Services analyses portfolio.
Highlighting where factors such as cell-line and bioreactor conditions have affected the structure, linkage or composition of glycans within a protein, it is also a key tool in helping to protect your business’s reputation for high-quality products.
At SGS, we have shaped our Glycosylation Analysis Service to meet the requirements of ICH 6QB, so you can be sure you are meeting regulatory expectations. Our post-translational modification analysis services include:
- Monosaccharide composition analysis
- Glycan population analysis
- Glycan antennary profiling analysis (including linkage analysis)
- Glycosylation site analysis
Our experts are always at hand to give advice on what may be most appropriate for you, whether you are using glycosylation analysis for drug discovery or at any stage of the drug manufacturing process.
SGS is a trusted partner throughout the Life Science industry, including the top 20 pharmaceutical companies. No matter what your glycoprotein analysis needs, we offer a commitment to quality and applying international expertise at a local level. Contact our experts today to find out more.